glp 1 agonist delayed gastric emptying GLP-1 Agonist-Induced – A Clinical Pharmacology Perspective GLP-1 Agonist Delayed Gastric Emptying:
Description
Tolerability: Tolerability: While the side effect profile of incretin mimetics is relatively mild (low rates of severe AEs
In addition, there is the potential for an increased incidence of hypersensitivity reactions such as injection-site reactions
& Jansson, T
Obesity in adults: a clinical practice guideline
inclusion criteria, follow-up period) (16), but it could be also due to peculiar and still unknown effects of each drug
